Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,488 papers from all fields of science
Search
Sign In
Create Free Account
Acomplia
Known as:
Zimulti
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
rimonabant
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
A review from patents inspired by the genus Cannabis
I. J. Flores-Sánchez
,
A. Ramos-Valdivia
Phytochemistry Reviews
2017
Corpus ID: 207225887
Specialized or secondary metabolism of plants from the genus Cannabis has been widely studied, generating a huge investment in…
Expand
Review
2017
Review
2017
The brain strikes back: Hypothalamic targets for peripheral CB1 receptor inverse agonism
D. Cota
Molecular Metabolism
2017
Corpus ID: 38523220
2010
2010
Heterocyclic synthesis using nitrilimines: part 14. Synthesis of new pyrazole derivatives
H. M. Dalloul
Turkish journal of chemistry
2010
Corpus ID: 94689617
A new series of 1,3,4,5-tetrasubstituted pyrazoles have been synthesized by the 1,3-dipolar cycloaddition of suitable…
Expand
Review
2009
Review
2009
Endocannabinoids, sperm biology and human fertility.
S. Lewis
,
M. Maccarrone
Pharmacological Research
2009
Corpus ID: 32577308
2008
2008
Endocannabinoids in Energy Homeostasis and Metabolic Disorders
I. Matias
,
V. Marzo
,
A. Köfalvi
2008
Corpus ID: 53312451
It has long been known that marihuana consumption acutely increases appetite (Hollister, 1971) and decreases body temperature…
Expand
2008
2008
Rimonabant in rats with a metabolic syndrome: good news after the depression
V. Di Marzo
,
A. Szallasi
British Journal of Pharmacology
2008
Corpus ID: 5500059
The synthetic cannabinoid CB1 receptor antagonist rimonabant (sold in the United Kingdom under the brand name Acomplia) was…
Expand
2007
2007
[A meta-analysis of the efficacy and safety of the anti-obesity agent Rimonabant].
R. Christensen
,
P. K. Kristensen
,
E. Bartels
,
H. Bliddal
,
A. Astrup
Ugeskrift for læger
2007
Corpus ID: 37195551
A meta-analysis of all randomised controlled trials examining the efficacy and safety of the anti-obesity agent Rimonabant…
Expand
2006
2006
Synthesis and structure-activity relationships (SARs) of 1,5-diarylpyrazole cannabinoid type-1 (CB(1)) receptor ligands for potential use in molecular imaging.
Sean R. Donohue
,
C. Halldin
,
V. Pike
Bioorganic & Medicinal Chemistry
2006
Corpus ID: 7051817
Review
2005
Review
2005
[Rimonabant (Acomplia), specific inhibitor of the endocannabinoid system].
Jean Ducobu
,
Jacques Sternon
Journal de pharmacie de Belgique
2005
Corpus ID: 28816507
The endocannabinoid system plays a major role in the regulation of body energy by stimulation of the appetite in the hypothalamus…
Expand
Review
2005
Review
2005
Cannabinoids and the regulation of ingestive behaviour.
S. Vickers
,
G. Kennett
Current Drug Targets
2005
Corpus ID: 37570409
Over past centuries, Cannabis sativa (Delta(9)-tetrahydrocannabinol being the principal active ingredient) has been used…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE